Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSGZ.L Regulatory News (SGZ)

  • There is currently no data for SGZ

Appendix 3B

16 Dec 2014 07:00

RNS Number : 8386Z
Scotgold Resources Ltd
15 December 2014
 



Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

SCOTGOLD RESOURCES LIMITED

 

ABN

42 127 042 773

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

Ordinary fully paid shares

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

281,897,707

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Ordinary fully paid shares

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

 

 

 

 

5

Issue price or consideration

 

$0.006 per share

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

Underwriter shares from Non Renounceable Rights Issue shortfall announced on 13 October 2014

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

28 November 2014

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

Nil

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

Nil

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

281,897,707

 

 

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

See Annexure 1.

 

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

15 December 2014

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

1,045,392,472

 

 

Ordinary Fully Paid Shares

 

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

3,000,000

 

 

 

26,222,222

 

 

 

 

153,161

 

 

 

7,111,111

 

 

 

 

50,000,000

 

 

 

30,000,000

Options

Exercise at A$0.08

Expiry 31 March 2022

 

Options

Exercise at £0.045 Expiry 24 July 2015

 

Options

Exercise at £0.031 Expiry 7 December 2015

 

Options

Exercise at £0.045

Expiry 28 March 2016

 

Options

Exercise at A$0.012

Expiry 31 March 2015

 

Options

Exercise at £0.069 Expiry 22 September 2017

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No plans to pay dividends at this stage

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

+Securities described in Part 1

 

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: ...................................................... Date: 15 December 2014

(Director/Company secretary)

 

Print name: Peter John Newcomb

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

221,565,739

Add the following:

• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid +ordinary securities that became fully paid in that 12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

148,519,802 6 January 2014

17,654,502 23 January 2014

194,965,196 26 November 2014

281,897,707 15 December 2014

 

90,000,000 5 March 2014

6,149,275 21 March 2014

75,640,251 8 August 2014

9,000,000 23 September 2014

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

NIL

"A"

1,045,392,472

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

156,808,870

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

Nil

"C"

Nil

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

156,808,870

Subtract "C"

Note: number must be same as shown in Step 3

Nil

Total ["A" x 0.15] - "C"

156,808,870

[Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

1,045,392,472

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

104,539,247

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

 

Nil

 

"E"

Nil

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

104,539,247

Subtract "E"

Note: number must be same as shown in Step 3

Nil

Total ["A" x 0.10] - "E"

104,539,247

Note: this is the remaining placement capacity under rule 7.1A

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFASFAELFAF
Date   Source Headline
17th Nov 20207:50 amRNSIssue of Equity and Total Voting Rights
17th Nov 20207:30 amEQSHardman & Co Research: Scotgold Resources (SGZ): High grade, low cost and up and running
9th Nov 202012:24 pmRNSHardman & Co Mining Investor Forum
26th Oct 202012:41 pmRNSShares and AJ Bell investor evening webinar
12th Oct 20204:41 pmRNSSecond Price Monitoring Extn
12th Oct 20204:35 pmRNSPrice Monitoring Extension
12th Oct 20207:00 amRNS£3m Placing to increase Cononish production rate
28th Sep 20207:00 amRNSGrampian Project Exploration Update
4th Sep 20207:00 amRNSCononish Gold & Silver Project Update
30th Jul 20208:20 amRNSOption Award and PCA Dealing
8th Jul 20207:00 amRNSCononish Development Activities Update
1st Jul 20204:17 pmRNSEMI Scheme and Grant of Options
12th Jun 20201:25 pmRNSCononish Development Activities Update
29th Apr 20207:00 amRNSFurther Amendment to Bridge Barn Loan Facility
31st Mar 202011:51 amRNSHalf-year Report
27th Mar 20207:00 amRNSCononish Development Schedule Update
5th Feb 20204:37 pmRNSIssue of Equity
15th Jan 202010:50 amRNSExploration Update
7th Jan 202012:21 pmRNSExercise of Options and Director Dealing
23rd Dec 20197:00 amRNSExercise of Options
16th Dec 20199:41 amRNSCononish Development Schedule Update
9th Dec 201912:08 pmRNSExercise of Options and Directors' Dealing
3rd Dec 20198:12 amRNSIssue of Equity
26th Nov 20193:07 pmRNSResult of AGM
25th Nov 20197:00 amRNSExploration Programme Clarification
20th Nov 20199:56 amRNSIssue of Equity
11th Nov 20195:11 pmRNSAnnual Results for the Year Ended 30 June 2019
7th Nov 201910:41 amRNSNotice of AGM
24th Oct 20197:00 amRNSGrampian Project Exploration Rights
22nd Oct 20199:25 amRNSIssue of Equity
15th Oct 201911:05 amRNSSecond Price Monitoring Extn
15th Oct 201911:00 amRNSPrice Monitoring Extension
14th Oct 20199:05 amRNSSecond Price Monitoring Extn
14th Oct 20199:00 amRNSPrice Monitoring Extension
28th Aug 201911:08 amRNSCononish Update, Fundraising & Exploration Update
15th Aug 20197:00 amRNSAppointment of Director
18th Jul 20197:00 amRNSPortugal Update
14th May 20197:00 amRNSAmendment to Option Conditions & Director Dealing
1st Apr 20197:00 amRNSExploration Update
21st Mar 20197:00 amRNSInterim Financial Report
26th Feb 20197:00 amRNSProject Update
29th Jan 20192:01 pmRNSDirector Dealing
10th Jan 201912:03 pmRNSConversion of Options and Issue of Equity
19th Dec 20187:00 amRNSInitiation of Development on 19th December 2018
27th Nov 20181:01 pmRNSResult of AGM
14th Nov 20182:27 pmRNSNotice of AGM
8th Nov 20183:07 pmRNSDirector Dealing
5th Nov 20181:58 pmRNSDirector Dealing
22nd Oct 20184:45 pmRNSDirector/PDMR Shareholding
22nd Oct 201812:50 pmRNSIssuance of decision notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.